00908nas a2200373   4500000000100000008004100001260000900042653001200051653002600063653002900089653001200118653002700130653003100157653000900188653002000197653002000217653001100237653002900248653001800277653001200295653000900307653001500316653002500331653001500356653001700371653001300388653001600401653001800417100001500435245005300450300001100503490000600514022001400520       1969                            d  c196910aAnimals10aAnti-Bacterial Agents10aClinical Trials as Topic10aDapsone10aDisease Models, Animal10aDrug Resistance, Microbial10aFoot10aGamma-Globulins10aGlucocorticoids10aHumans10aImmunosuppressive Agents10aImmunotherapy10aleprosy10aMice10aMuramidase10aMycobacterium leprae10aPhenazines10aSulfonamides10aSulfones10aThalidomide10aThioacetazone1 aBrowne S G00aThe evaluation of present antileprosy compounds.  a211-510 v7  a0568-0123